{
    "@graph": [
        {
            "@id": "gnd:1032505311",
            "sameAs": "Betz, Christine"
        },
        {
            "@id": "gnd:4136176-3",
            "sameAs": "Kristallstruktur"
        },
        {
            "@id": "gnd:4308985-9",
            "sameAs": "Kristallk\u00f6rper"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A737429348",
            "@type": "bibo:Thesis",
            "P1053": "Online-Ressource",
            "identifier": [
                "(ppn)737429348",
                "(firstid)BSZ:37945243X",
                "(contract)FRUB-opus-8925"
            ],
            "subject": [
                "(classificationName=linseach:mapping)bio",
                "(classificationName=ddc)540",
                "(classificationName=ddc-dbn)540",
                "(classificationName=ddc-dbn)570",
                "(classificationName=linseach:mapping)che"
            ],
            "title": "Structural characterization of the metal-binding ligands S100A8/S100A9 and S100B of the receptor for advanced glycation end products",
            "abstract": [
                "Zusammenfassung: S100B, S100A8 and S100A9 are members of the family of S100 proteins only found in vertebrates. They feature a four-\u03b1-helical structure with two Ca2+-binding EF-hand-loops per monomer forming dimers or higher oligomers. Homodimeric S100B is mainly expressed in astrocytes and is involved e. g. in neurite extension or apoptosis dependent on its concentration. Besides Ca2+, it also binds Zn2+ and Cu2+ with high affinity. In the C-terminus S100B contains a cysteine residue (Cys84) that is conserved in many S100 proteins. This Cys84 is located in helix IV of S100B and influences the neurotrophic function and binding affinity of S100B towards target molecules or Zn2+. Its structural impact was investigated by X-ray crystallographic analysis of the Cys84-to-Ser mutant (S100BMT). S100BMT was expressed, purified, and crystallized in the presence and absence of Zn2+. Crystals of S100BMT-Ca-Zn diffracted to a resolution of 1.2 \u00c5, crystals of S100BMT-Ca to a resolution of 1.7 \u00c5. Both structures were solved by molecular replacement. Like in wild-type S100B, Zn2+ is coordinated tetrahedrally by residues His15 and His25 of one subunit and His85 and Glu89 from the second subunit. Two additional unspecific Zn2+ sites were observed in S100BMT-Ca-Zn, where Zn2+ is coordinated by His42 and by an acetate from the crystallization buffer. Superposition of the structures of wild-type S100B and S100BMT revealed that the C-terminal helix IV of S100BMT-Ca was shortened by six residues. Zn2+ binding to S100BMT reversed the effect of the mutation and stabilized full-length helix IV. Thus, Cys84 is required for the stabilization of helix IV in S100B. S100A8 and S100A9 are highly expressed by monocytes and neutrophils and secreted at sites of pathogenic invasion and inflammation. Both proteins act in their heteromeric form as chemokines or cytokines and activate the receptor for advanced glycation end products (RAGE) and the Toll-like receptor 4 (TLR-4) of the innate immunity. The quinoline-3-carboxamide compound ABR-215757 and the monoclonal antibody Fab43/8 block the interaction of S100A9 with these receptors. They therefore can inhibit specifically the activation of signaling pathways leading to pathologies associated with RAGE and TLR-4. To get detailed insight into the binding mechanism of S100A9 with its inhibitors, S100A9 was expressed and purified. Moreover, a complex of S100A9 and Fab43/8 was successfully purified. S100A9 was crystallized and crystals w ...",
                "Zusammenfassung: S100B, S100A8 und S100A9 geh\u00f6ren zur Familie der S100-Proteine, welche nur in Vertebraten vorkommen. Gemeinsames Merkmal dieser Proteine ist ihre Struktur mit vier \u03b1-Helices und zwei Ca2+-bindenden EF-H\u00e4nden je Monomer. S100-Proteine bilden Dimere oder h\u00f6here Oligomere. Das Homodimer S100B wird haupts\u00e4chlich in Astrozyten exprimiert und reguliert im ZNS Wachstum von Neuriten oder Apoptose von Neuronen, abh\u00e4ngig von der Konzentration dieses Proteins. Neben Ca2+ bindet S100B auch Zn2+ und Cu2+ mit hoher Affinit\u00e4t. S100B enth\u00e4lt im C-Terminus ein hochkonserviertes Cystein (Cys84), welches f\u00fcr die Funktion von S100B eine zentrale Rolle zu spielen scheint. Cys84 liegt in Helix IV von S100B und beeinflusst die Bindung von Zn2+, die Bindung von S100B-regulierten Zielproteinen und dessen neurotrophe Funktion. Welche strukturelle Rolle dieses Cys84 f\u00fcr S100B spielt, wurde hier mittels R\u00f6ntgenstrukturanalyse der Cys84-Ser84-Mutante von S100B (S100BMT) kristallographisch untersucht. Hierf\u00fcr wurde S100BMT exprimiert, isoliert und in Anwesenheit und Abwesenheit von Zn2+ kristallisiert. Kristalle von S100BMT-Ca-Zn beugten die R\u00f6ntgenstrahlung bis zu einer Aufl\u00f6sung von 1.2 \u00c5, S100BMT-Ca-Kristalle bis zu einer Ausl\u00f6sung von 1.7 \u00c5. Beide Strukturen wurden durch die Methode des Molekularen Ersatzes gel\u00f6st. Wie im Wildtyp-Protein war auch in S100BMT-Ca-Zn das Zn2+ tetrahedral durch die Reste His15 und His25 der einen Untereinheit und durch His85 und Glu89 der zweiten Untereinheit des Homodimers koordiniert. His42 und ein Azetat des Kristallisationspuffers bildeten zwei weitere unspezifische Zn2+-Bindestellen in S100BMT-Ca-Zn. Struktur\u00fcberlagerungen von S100BWT-Ca und S100BMT-Ca zeigten in der Struktur von S100BMT-Ca eine Verk\u00fcrzung der C-terminalen Helix IV um sechs Reste. Diese Struktur\u00e4nderung wurde durch die Bindung von Zn2+ wieder aufgehoben, wie die Struktur von S100BMT-Ca-Zn zeigte. Cys84 ist somit essentiell f\u00fcr die Stabilisierung von Helix IV in S100B. S100A8 und S100A9 werden von Monozyten und Neutrophilen exprimiert und an Entz\u00fcndungsherden sowie bei der Invasion verschiedener Pathogene sekretiert. Beide Proteine wirken in ihrer heteromeren Form als Chemokine oder Zytokine und aktivieren den Rezeptor f\u00fcr Advanced Glycation Endproducts (RAGE) und den Toll-like Rezeptor 4 (TLR4) des angeborenen Immunsystems. Die Quinolin-3-Carboxamid-Verbindung ABR-215757 und der monoklonale Antik\u00f6rper Fab43/8 blo ..."
            ],
            "alternative": [
                "Strukturelle Charakterisierung der metallbindenden Liganden S100A8/S100A9 und S100B des Rezeptors f\u00fcr Advanced Glycation End Products",
                "\u00dcbers. des Hauptsacht.: Strukturelle Charakterisierung der metallbindenden Liganden S100A8/S100A9 und S100B des Rezeptors f\u00fcr Advanced Glycation End Products"
            ],
            "contributor": "Technische Informationsbibliothek (TIB)",
            "creator": "gnd:1032505311",
            "isPartOf": "(collectioncode)GBV-ODiss",
            "issued": "2013",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "open access",
            "medium": "rda:termList/RDACarrierType/1018",
            "dcterms:subject": [
                {
                    "@id": "gnd:4136176-3"
                }
            ]
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "title": "http://purl.org/dc/elements/1.1/title",
        "creator": {
            "@id": "http://purl.org/dc/terms/creator",
            "@type": "@id"
        },
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "alternative": "http://purl.org/dc/terms/alternative",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "abstract": "http://purl.org/dc/terms/abstract",
        "license": "http://purl.org/dc/terms/license",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "contributor": "http://purl.org/dc/terms/contributor",
        "issued": "http://purl.org/dc/terms/issued",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}